1. Home
  2. Active Ingredient Index
  3. Filgrastim

Active Ingredient Filgrastim

Active Ingredient Details

What is Filgrastim?

A recombinant granulocyte colony-stimulating factor (G-CSF) that is used in the treatment and prevention of NEUTROPENIA, preparation and collection of blood progenitor cells, and for use in PERIPHERAL BLOOD STEM CELL TRANSPLANTATION.

What is the usage for Filgrastim?

Filgrastim is a man-made version of a certain natural substance made in your body. It is used to help your body make more white blood cells. White blood cells are important to help you fight off infections. Filgrastim is given to people whose ability to make white blood cells is reduced (for instance, due to chemotherapy, chronic neutropenia, or exposure to large amounts of radiation). It is also used in certain treatment procedures (such as bone marrow/stem cell transplant). This monograph is about the following filgrastim products: filgrastim, tbo-filgrastim, filgrastim-sndz, and filgrastim-aafi.

How many products in the NDC database contain Filgrastim?

The NDC database has 19 products with the active ingredient Filgrastim. The following table lists all the products that have this active ingredient.

NDC Products with Filgrastim

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0069-0291Proprietary Name: Nivestym Filgrastim-aafiInjection, SolutionSubcutaneousPfizer Laboratories Div Pfizer IncACTIVE
0069-0292Proprietary Name: Nivestym Filgrastim-aafiInjection, SolutionSubcutaneousPfizer Laboratories Div Pfizer IncACTIVE
0069-0293Proprietary Name: Nivestym Filgrastim-aafiInjection, SolutionIntravenous; SubcutaneousPfizer Laboratories Div Pfizer IncACTIVE
0069-0294Proprietary Name: Nivestym Filgrastim-aafiInjection, SolutionIntravenous; SubcutaneousPfizer Laboratories Div Pfizer IncACTIVE
55513-209Proprietary Name: Neupogen FilgrastimInjection, SolutionIntravenous; SubcutaneousAmgen IncACTIVE
55513-530Proprietary Name: Neupogen FilgrastimInjection, SolutionIntravenous; SubcutaneousAmgen IncACTIVE
55513-546Proprietary Name: Neupogen FilgrastimInjection, SolutionIntravenous; SubcutaneousAmgen IncACTIVE
55513-924Proprietary Name: Neupogen FilgrastimInjection, SolutionIntravenous; SubcutaneousAmgen IncACTIVE
61314-318Proprietary Name: Zarxio Filgrastim-sndzInjection, SolutionIntravenous; SubcutaneousSandoz Inc.ACTIVE
61314-326Proprietary Name: Zarxio Filgrastim-sndzInjection, SolutionIntravenous; SubcutaneousSandoz Inc.ACTIVE
63459-910Proprietary Name: Granix Tbo-filgrastimInjection, SolutionSubcutaneousCephalon, LlcACTIVE
63459-912Proprietary Name: Granix Tbo-filgrastimInjection, SolutionSubcutaneousCephalon, LlcACTIVE
63459-918Proprietary Name: Granix Tbo-filgrastimInjection, SolutionSubcutaneousCephalon, LlcACTIVE
63459-920Proprietary Name: Granix Tbo-filgrastimInjection, SolutionSubcutaneousCephalon, LlcACTIVE
70121-1568Proprietary Name: Releuko FilgrastimInjection, SolutionIntravenous; SubcutaneousAmneal Pharmaceuticals LlcACTIVE
70121-1569Proprietary Name: Releuko FilgrastimInjection, SolutionIntravenous; SubcutaneousAmneal Pharmaceuticals LlcACTIVE
70121-1570Proprietary Name: Releuko FilgrastimInjection, SolutionIntravenous; SubcutaneousAmneal Pharmaceuticals LlcACTIVE
70121-1571Proprietary Name: Releuko FilgrastimInjection, SolutionIntravenous; SubcutaneousAmneal Pharmaceuticals LlcACTIVE
71861-0001Proprietary Name: FilgrastimLiquidHospira Zagreb D.o.o.ACTIVE
<